The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

The global AI In Healthcare Market size is projected to be valued at USD 26.6 Billion in 2024 and reach USD 187.7 billion by 2030, growing at ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the use of AI in clinical trials, the technology is still leaps and bounds ...

Drug services firms are no ... which invests in companies developing AI and automation solutions, says the CDMO industry isn’t a leader in AI adoption or in developing innovative AI technologies.

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a generative AI-based system for speeding up drug review - and plans to roll out ...

As pharmaceutical companies adopt AI technologies, it is essential to explore the opportunities and challenges they present in the quest for innovative healthcare solutions. Traditional drug ...

From easing clinician workloads to enabling faster, smarter diagnoses, these practical AI tools are transforming healthcare ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...